APPLICATION OF CELESTINE BLUE B AND GALLOCIANINE FOR STUDYING THE INFLUENCE OF DRUGS ON THE REACTIVE OXYGEN AND HALOGEN SPECIES PRODUCTION BY NEUTROPHILS
Abstract
We investigated the influence of drugs (dapsone, paracetamol and isoniazid) on the reactive oxygen and halogen species production by neutrophils. The standard fluorescent method based on scopoletin, as well as the recently developed fluorescent methods based on oxazine dyes, celestine blue B and gallocyanine, were used for this purpose. Celestine blue B selectively reacts with hypochlorous acid, and gallocyanine reacts mainly with the superoxide radical anion, which permits to reveal the regulatory effect of anti-inflammatory drugs on the neutrophil NADPH-oxidase and myeloperoxidase activity, responsible for the reactive oxygen and halogen species production, respectively. The obtained results indicate that gallocyanine and celestine blue B dyes are promising chemosensors to study the effect of drugs used in anti-inflammatory therapy on the neutrophils respiratory burst.
About the Authors
V. E. Reut
Belarusian State University
Belarus
Minsk, 220030
Belarus
Minsk, 220030
D. V. Grigorieva
Belarusian State University
Belarus
Minsk, 220030
Belarus
Minsk, 220030
I. V. Gorudko
Belarusian State University
Belarus
Minsk, 220030
Belarus
Minsk, 220030
A. V. Sokolov
Institute of Experimental Medicine; St. Petersburg State University; Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency
Russian Federation
Russian Federation
St. Petersburg, 197376
St. Petersburg, 199034
Moscow, 119435
O. M. Panasenko
Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Pirogov Russian National Research Medical University
Russian Federation
Russian Federation
Moscow, 119435
Moscow, 117997
References
1. N. V. Vorobjeva, B. V. Pinegin. Biochem. Mosc., 79, N 12 (2014) 1286—1296
2. P. H. Leliefeld, C. M. Wessels, L. P. Leenen, L. Koenderman, J. Pillay. Crit. Care, 20, N 1 (2016) 73—81
3. M. Colitti, B. Stefanon, G. Gabai, M. Gelain, F. Bonsembiante. Antioxidants, 8, N 1 (2019) 28—46
4. A. Manda-Handzlik, U. Demkow. In: Pulmonary Infection, Ed. M. Pokorski, Springer, Cham (2015) 51—60
5. C. Nathan, A. Cunningham-Bussel. Nat. Rev. Immunol., 13, N 5 (2013) 349—361
6. F. Vatansever, W. C. de Melo, P. Avci, D. Vecchio, M. Sadasivam, A. Gupta, R. Chandran, M. Karimi, N. A. Parizotto, R. Yin, G. P. Tegos, M. R. Hamblin. FEMS Microbiol. Rev., 37, N 6 (2013) 955—989
7. G. Dent, K. F. Rabe, H. Magnussen. Br. J. Pharmacol., 122, N 4 (1997) 758—764
8. K. Brieger, S. Schiavone, Jr. Miller, K. Krause. Swiss Med. Wkly., 142 (2012) 13659—13664
9. A. Phaniendra, D. B. Jestadi, L. Periyasamy. Indian J. Clin. Biochem., 30, N 1 (2015) 11—26
10. N. D. Vaziri, B. Rodríguez-Iturbe. Nat. Clin. Pract. Nephrol., 2, N 10 (2006) 582—593
11. E. Malle, P. G. Furtmüller, W. Sattler, C. Obinger. Br. J. Pharmacol., 152, N 6 (2007) 838—854
12. С. О. Козлов, И. В. Кудрявцев, Н. А. Грудинина, А. В. Костевич, О. М. Панасенко, А. В. Соколов, В. Б. Васильев. Acta Biomed. Sci., 1, N 2-3 (2016) 86—91
13. В. Е. Луценко, Д. В. Григорьева, И. В. Горудко, О. М. Панасенко, А. В. Соколов, С. Н. Черенкевич. Докл. НАН Беларуси, 63, № 6 (2019) 730—735
14. В. Е. Луценко, Д. В. Григорьева, И. В. Горудко, С. Н. Черенкевич, Н. П. Горбунов, В. А. Костевич, О. М. Панасенко, А. В. Соколов. Мед. акад. журн., 19, № 2 (2019) 63—71
15. World Health Organization N WHO/MVP/EMP/IAU/2019.06 (2019) 1—60
16. G. Wozel, C. Blasum. Arch. Dermatol. Res., 306, N 2 (2014) 103—124
17. J. A. Uetrecht, N. A. Zahid, N. H. Shear, W. D. Biggar. J. Pharmacol. Exp. Ther., 245, N 1 (1988) 274—279
18. M. D. Coleman. Br. J. Dermatol., 129, N 5 (1993) 507—513
19. S. M. Debol, M. J. Herron, R. D. Nelson. J. Leukoc. Biol., 62, N 6 (1997) 827—836
20. P. M. Bozeman, D. B. Learn, E. L. Thomas. Biochem. Pharmacol., 44, N 3 (1992) 553—563
21. A. V. Sokolov, V. A. Kostevich, S. O. Kozlov, I. S. Donskyi, I. I. Vlasova, A. O. Rudenko, E. T. Zakharova, V. B. Vasilyev, O. M. Panasenko. Free Radic. Res., 49, N 6 (2015) 777—789
22. M. Freitas, V. M. Costa, D. Ribeiro, D. Couto, G. Porto, F. Carvalho, E. Fernandes. Toxicol. Lett., 219, N 2 (2013) 170—177
23. H. S. Smith. Pain Phys., 12, N 1 (2009) 269—280
24. M. Koelsch, R. Mallak, G. G. Graham, T. Kajer, M. K. Milligan, L. Q. Nguyen, D. W. Newsham, J. S. Keh, A. J. Kettle, K. F. Scott, J. B. Ziegler, D. I. Pattison, S. Fu, C. L. Hawkins, M. D. Rees, M. J. Davies. Biochem. Pharmacol., 79, N 8 (2010) 1156—1164
25. H. Jaeschke. Hepatology, 43, N 6 (2006) 1191—1194
26. H. Jaeschke, M. R. McGill, A. Ramachandran. Drug Metab. Rev., 44, N 1 (2012) 88—106
27. H. Jaeschke. Toxicol. Lett., 144, N 3 (2003) 279—288
28. P. Wang, K. Pradhan, X. Zhong, X. Ma. Acta Pharm. Sin. B, 6, N 5 (2016) 384—392
29. S. R. Khan, A. G. Morgan, K. Michail, N. Srivastava, R. M. Whittal, N. Aljuhani, A. G. Siraki. Biochem. Pharmacol., 106 (2016) 46—55
30. L. V. Forbes, P. G. Furtmüller, I. Khalilova, R. Turner, C. Obinger, A. J. Kettle. Biochem. Pharmacol., 84 (2012) 949–960
31. I. V. Gorudko, A. V. Mukhortava, B. Caraher, M. Ren, S. N. Cherenkevich, G. M. Kelly, A. V. Timoshenko. Arch. Biochem. Biophys., 516, N 2 (2011) 173—181
32. В. Е. Луценко, Д. В. Григорьева, С. Н. Черенкевич, О. М. Панасенко, А. В. Соколов, И. В. Горудко. Актуальные вопр. биол. физики и химии, 3, № 3 (2018) 612—618
33. G. T. Nguyen, E. R. Green, J. Mecsas. Front. Cell. Infect. Microbiol., 7 (2017) 373—396
34. F. R. Sheppard, M. R. Kelher, E. E. Moore, N. J. McLaughlin, A. Banerjee, C. C. Silliman. J. Leukoc. Biol., 78, N 5 (2005) 1025—1042
35. J. Nagaji. Kurume Med. J., 46, N 3–4 (1999) 157—162
36. H. Rosen, S. J. Klebanoff. J. Exp. Med., 149, N 1 (1979) 27—39
37. В. Е. Луценко, Д. В. Григорьева, И. В.Горудко, Е. В. Шамова, А. В. Соколов, С. Н. Черенкевич, О. М. Панасенко. Сб. ст. междунар. конф. "Рецепторы и внутриклеточная сигнализация", 20—24 мая 2019 г., Пущино, 2 (2019) 823—827
38. P. J. O'Brien, S. Khan, S. D. Jatoe. In: Biological Reactive Intermediates IV, Eds. C. M. Witmer, R. R. Snyder, D. J. Jollow, G. F. Kalf, J. J. Kocsis, I. G. Sipes, Plenum Press, New York (1991) 51—64
39. M. Bedner, W. A. MacCrehan. Environ. Sci. Technol., 40, N 2 (2006) 516—522
40. A. Hillar, P. C. Loewen. Arch. Biochem. Biophys., 323, N 2 (1995) 438—446
41. V. Bogdandi, G. Lente, I. Fabian. RSC Adv., 5, N 83 (2015) 67500—67508
42. S. M. Debol, M. J. Herron, R. D. Nelson. J. Leukoc. Biol., 62, N 6 (1997) 827—836
43. T. Suda, Y. Suzuki, T. Matsui, T. Inoue, O. Niide, T. Yoshimaru, H. Suzuki, C. Ra, T. Ochiai. Br. J. Dermatol., 152, N 5 (2005) 887—895
44. D. W. Choi, B. Leininger-Muller, Y. C. Kim, P. Leroy, G. Siest, M. Wellman. Free Radic. Res., 36, N 8 (2002) 893—903
45. B. Okuyan, F. V. Izzettin, M. Sancar, Ö. Ertaş, A. Çevikbaş, Ü. S. Gürer. Int. Immunopharmacol., 5, N 7-8 (2005) 1337—1342
46. B. M. Zeis. Chemotherapy, 34, N 1 (1988) 56—60
47. L. G. Kielland, R. A. Vage, G. E. Eide, S. Sørnes, A. Naess. Chemotherapy, 57, N 4 (2011) 339—344
Review
For citations:
Reut V.E., Grigorieva D.V., Gorudko I.V., Sokolov A.V., Panasenko O.M. APPLICATION OF CELESTINE BLUE B AND GALLOCIANINE FOR STUDYING THE INFLUENCE OF DRUGS ON THE REACTIVE OXYGEN AND HALOGEN SPECIES PRODUCTION BY NEUTROPHILS. Zhurnal Prikladnoii Spektroskopii. 2020;87(4):637-645. (In Russ.)
Views: 330
Email this article 